Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Ajelli and Cécile Viboud.
Marco Ajelli
Connection Strength
1.045
Cécile Viboud
  1. The RAPIDD ebola forecasting challenge: Synthesis and lessons learnt. Epidemics. 2018 03; 22:13-21.
    View in: PubMed
    Score: 0.183
  2. Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China. Clin Infect Dis. 2021 07 01; 73(1):e79-e85.
    View in: PubMed
    Score: 0.060
  3. Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. Nat Hum Behav. 2021 08; 5(8):1009-1020.
    View in: PubMed
    Score: 0.060
  4. The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China. Sci Adv. 2021 05; 7(19).
    View in: PubMed
    Score: 0.059
  5. Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun. 2021 Apr 30; 12(1):2561.
    View in: PubMed
    Score: 0.059
  6. Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun. 2021 Apr 08; 12(1):2251.
    View in: PubMed
    Score: 0.059
  7. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun. 2021 03 09; 12(1):1533.
    View in: PubMed
    Score: 0.058
  8. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021 05; 9(5):e598-e609.
    View in: PubMed
    Score: 0.058
  9. Who should be prioritized for COVID-19 vaccination in China? A descriptive study. BMC Med. 2021 02 10; 19(1):45.
    View in: PubMed
    Score: 0.058
  10. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ. 2020 12 15; 371:m4704.
    View in: PubMed
    Score: 0.057
  11. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021 01 15; 371(6526).
    View in: PubMed
    Score: 0.057
  12. Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China. Nat Commun. 2020 10 27; 11(1):5411.
    View in: PubMed
    Score: 0.057
  13. Health-seeking behaviors of patients with acute respiratory infections during the outbreak of novel coronavirus disease 2019 in Wuhan, China. Influenza Other Respir Viruses. 2021 03; 15(2):188-194.
    View in: PubMed
    Score: 0.056
  14. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science. 2020 06 26; 368(6498):1481-1486.
    View in: PubMed
    Score: 0.055
  15. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020 07; 20(7):793-802.
    View in: PubMed
    Score: 0.055
  16. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020 04 24; 368(6489):395-400.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.